Evista and Hyperglycemia - a phase IV clinical study of FDA data

Summary:

Hyperglycemia is reported as a side effect among people who take Evista (raloxifene hydrochloride), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Singulair, and have Systemic lupus erythematosus.

The phase IV clinical study analyzes which people have Hyperglycemia when taking Evista. It is created by eHealthMe based on reports of 25,442 people who have side effects when taking Evista from the FDA, and is updated regularly.

What is Evista?

Evista has active ingredients of raloxifene hydrochloride. It is often used in osteoporosis. eHealthMe is studying from 25,891 Evista users. Check the latest studies of Evista.

What is Hyperglycemia?

Hyperglycemia (high blood sugar) is found to be associated with 1,660 drugs and 2,500 conditions by eHealthMe. Check the latest studies of Hyperglycemia.

On Aug, 06, 2026

25,442 people reported to have side effects when taking Evista.
Among them, 78 people (0.31%) have Hyperglycemia.

Among these 78 people:

How long have people been on Evista when they have Hyperglycemia? *

What is the gender of people who have Hyperglycemia when taking Evista? *

female: 98.67 %
male: 1.33 %

What is the age of people who have Hyperglycemia when taking Evista? *

What are other drugs people take besides Evista? *

What are other side effects people have besides Hyperglycemia? *

Tooth Disorder (tooth disease): 39 people, 50.00%
Osteoarthritis (a joint disease caused by cartilage loss in a joint): 39 people, 50.00%
Sinusitis (inflammation of sinus): 34 people, 43.59%
Osteomyelitis (infection of bone): 34 people, 43.59%
Diarrhea: 34 people, 43.59%
Swelling: 33 people, 42.31%
Periodontal Disease (disease that attacks the gum and bone and around the teeth): 32 people, 41.03%
Gums - Swollen: 32 people, 41.03%
Bone Disorder: 32 people, 41.03%
Mouth Ulcers: 32 people, 41.03%

What are the existing conditions these people have? *

Systemic Lupus Erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue): 19 people, 24.36%
Multiple Myeloma (cancer of the plasma cells): 13 people, 16.67%
Urticaria Pigmentosa (skin disease that produces patches of darker skin (lesions) and very bad itching): 12 people, 15.38%
Insomnia (sleeplessness): 6 people, 7.69%
Diabetes: 5 people, 6.41%
Parkinson's Disease: 4 people, 5.13%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 4 people, 5.13%
Osteoarthritis (a joint disease caused by cartilage loss in a joint): 4 people, 5.13%
Pain: 4 people, 5.13%
Cardiac Failure: 4 people, 5.13%

* Approximation only. Some reports may have incomplete information.

Do you take Evista and have Hyperglycemia?

- Check whether Hyperglycemia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Evista:

Evista (25,891 reports)

Hyperglycemia treatments and more:

Hyperglycemia (48,691 reports)

Browse all side effects of Evista:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hyperglycemia:

Hyperglycemia (1,660 drugs)

Browse all the conditions that are associated with Hyperglycemia:

Hyperglycemia (2,500 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on raloxifene hydrochloride (the active ingredients of Evista) and Evista (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.